GSK3145095 - Moligand™, ≥99% , Inhibitor of receptor interacting serine/threonine kinase 1, CAS No.1622849-43-7, Inhibitor of receptor interacting serine/threonine kinase 1

CAS: 1622849-43-7 Cat. No.: G414217 Fórmula: C20H17F2N5O2 Peso molecular: 397.38
Disponible para pedir
CALIDAD & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥99%
Synonyms
5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide|(S)-5-Benzyl-N-(7,9-difluoro-2-oxo-2,3,4,5-tetrahydro-1hbenzo(b)azepin-3-yl)-1H-1,2,4-triazole-3-carboxamide (7,7-dimethyl-2- oxobicyclo(2.2.1)heptan-1-yl)|GSK3145095|GSK-3145095|GSK-3145095; GSK 3145095|(S)-5-benzyl-N-(7,9-difluoro-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Talla
Alemania (EU)
USA*
Precio
Cantidad
1mg
G414217-1mg
Fabricado bajo pedido · 8–12 semanas
99,70€
5mg
G414217-5mg
Fabricado bajo pedido · 8–12 semanas
347,88€
10mg
G414217-10mg
—
2 Disponible
543,99€
25mg
G414217-25mg
Fabricado bajo pedido · 8–12 semanas
1.027,32€
50mg
G414217-50mg
—
2 Disponible
1.812,62€
Enter a quantity for the sizes you want to add.

Descripción general

Information

GSK3145095 GSK3145095 is a potent and orally active RIP1 kinase inhibitor with IC50 of 6.3 nM with potential antineoplastic and immunomodulatory activities.


Targets

RIP1 kinase (Cell-free assay) 6.3 nM


In vitro

GSK3145095 potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking RIP1 kinasedependent cellular responses. Highlighting its potential as a novel cancer therapy, the inhibitor is also able to promote a tumor suppressive T cell phenotype in pancreatic adenocarcinoma organ cultures.


Cell Research(from reference)

Cell lines:U937 cells, L-cells NCTC 929 (L929) cells 

Concentrations:0-3 μM 

Incubation Time:5 h 

Especificaciones

Sinónimos
5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide | (S)-5-Benzyl-N-(7,9-difluoro-2-oxo-2,3,4,5-tetrahydro-1hbenzo(b)azepin-3-yl)-1H-1,2,4-triazole-3-carboxamide (7,7-dimethyl-2- oxobicyclo(2.2.1)heptan-1-yl) | GSK3145095 | GSK-3145095 | GSK-3145095; GSK 3145095 | (S)-5-benzyl-N-(7,9- Show more
Especificaciones y pureza
Moligand™, ≥99%
Mecanismos bioquímicos y fisiológicos
GSK3145095 is a potent and orally active RIP1 kinase inhibitor with IC50 of 6.3 nM with potential antineoplastic and immunomodulatory activities.
Condiciones de almacenamiento de almacenamiento
Store at -20°C
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Grado
Moligand™
Tipo de acción
INHIBITOR
Mecanismo de acción
Inhibitor of receptor interacting serine/threonine kinase 1
Pureza
≥99%
Propiedades del producto
ALogP
2.573
hba_count
4
Recuento HBD
3
Enlace rotable
4
Nombres e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504772873
SMILES
C1CC2=C(C(=CC(=C2)F)F)NC(=O)C1NC(=O)C3=NNC(=N3)CC4=CC=CC=C4
IUPAC Name
5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide
InChIKey
ATQAGKAMBISZQM-HNNXBMFYSA-N
InChI
1S/C20H17F2N5O2/c21-13-9-12-6-7-15(19(28)25-17(12)14(22)10-13)23-20(29)18-24-16(26-27-18)8-11-4-2-1-3-5-11/h1-5,9-10,15H,6-8H2,(H,23,29)(H,25,28)(H,24,26,27)/t15-/m0/s1
Isómeros SMILES
C1CC2=C(C(=CC(=C2)F)F)NC(=O)[C@H]1NC(=O)C3=NNC(=N3)CC4=CC=CC=C4
Peso molecular
397.38
Reaxys
60346311
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=60346311&ln=

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganic acids and derivatives
ClaseCarboxylic acids and derivatives
SubclassAmino acids, peptides, and analogues
Intermediate Tree Nodes Amino acids and derivatives - Alpha amino acids and derivatives
Direct ParentN-acyl-alpha amino acids and derivatives
Alternative Parents Benzazepines  2-heteroaryl carboxamides  Azepines  Benzene and substituted derivatives  Aryl fluorides  Triazoles  Heteroaromatic compounds  Secondary carboxylic acid amides  Lactams  Azacyclic compounds  Organopnictogen compounds  Organonitrogen compounds  Organofluorides  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents N-acyl-alpha amino acid or derivatives - Benzazepine - 2-heteroaryl carboxamide - Azepine - Benzenoid - Monocyclic benzene moiety - Aryl halide - Aryl fluoride - Heteroaromatic compound - 1,2,4-triazole - Azole - Secondary carboxylic acid amide - Lactam - Carboxamide group - Azacycle - Organoheterocyclic compound - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Organofluoride - Organohalogen compound - Carbonyl group - Aromatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom.
External Descriptors Not available
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
RIPK1 Tchem Receptor-interacting serine/threonine-protein kinase 1 (8 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

2 results found

Lot NumberCertificate TypeFechaArticulo
I2216048I2216048Certificate of AnalysisJun 10, 2025 G414217
I2216049I2216049Certificate of AnalysisJun 10, 2025 G414217
Propiedades químicas y físicas
SolubilidadSolubility (25°C) In vitro DMSO: 79 mg/mL (198.8 mM); Ethanol: 6 mg/mL (15.09 mM); Water: Insoluble;
DMSO (mg/ml) Solubilidad máxima79
DMSO (mM) Solubilidad máxima198.802154109417
Agua (mg/ml) Solubilidad máxima<1
Peso molecular397.4
XLogP33.100
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count6
Rotatable Bond Count4
Exact Mass397.135 Da
Monoisotopic Mass397.135 Da
Topological Polar Surface Area99.800 Ų
Heavy Atom Count29
Formal Charge0
Complexity603.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Seguridad y peligros (GHS)
Reaxys
60346311
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=60346311&ln=
Calculadoras de soluciones
Reseñas

Reseñas de cliente

¿Necesita ayuda para elegir la calidad?

Nuestra guía de selección de calidades cubre la pureza, el estado del estabilizador y la idoneidad de la aplicación para todas las variantes de nuestro catálogo.

Ver la guía de calidades Moligand™ →

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.